Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antiviral”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT01964755
What this trial is testing

Chemotherapy for Relapsed Epstein Barr Virus Associated Lymphoma

Who this might be right for
Epstein Barr Virus Associated Non Hodgkin's LymphomaEpstein Barr Virus Associated Hodgkin's LymphomaPost-Transplant Lymphoproliferative Disease
University of Miami 6
Testing effectiveness (Phase 2)Study completedNCT00002571
What this trial is testing

SWOG-9320 Combination Chemotherapy, Radiation Therapy, and Antiviral Therapy in Treating Patients With AIDS-Related Lymphoma

Who this might be right for
Lymphoma
SWOG Cancer Research Network 52
Testing effectiveness (Phase 2)Ended earlyNCT04536532
What this trial is testing

Evaluation HEC121120 Tolerance in Healthy Subjects and Patients With Chronic Hepatitis B, Pharmacokinetics Characteristics and Antiviral Activity of Ⅰ Phase of Study

Who this might be right for
Hepatitis B, Chronic
Sunshine Lake Pharma Co., Ltd. 52
Post-approval studies (Phase 4)Ended earlyNCT04999098
What this trial is testing

Echinaforce COVID-19 Shedding Study

Who this might be right for
COVID-19 Respiratory InfectionSARS-CoV2 Infection
A. Vogel AG 40
Testing effectiveness (Phase 2)UnknownNCT01242787
What this trial is testing

Long-term Safety and Efficacy Study of LB80380 in the Treatment-naive Patients of Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis B
LG Life Sciences 115
Not applicableNot Yet RecruitingNCT07727187
What this trial is testing

Hepatitis B Infection Surveillance

Who this might be right for
Chronic Hepatitis B Infection
Assistance Publique - Hôpitaux de Paris 1,360
Not applicableLooking for participantsNCT07679412
What this trial is testing

Evaluation of Safety and Efficacy of Autologous LB-DTK-CMV in Patients With Antiviral-Resistant and Refractory Cytomegalovirus Retinitis.

Who this might be right for
CMV Retinitis
LucasBio 5
Large-scale testing (Phase 3)Study completedNCT01973049
What this trial is testing

UNITY 2: A Study of an Investigational Treatment Regimen of DCV+ASV+BMS-791325 in a Fixed Dose Combination (the DCV 3DAA (Direct Acting Antiviral) Regimen) With or Without RBV for 12 Weeks for the Treatment of Chronic Hepatitis C Virus(HCV)Genotype 1 Infection in Subjects With Compensated Cirrhosis

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 202
Large-scale testing (Phase 3)Study completedNCT00737568
What this trial is testing

Tenofovir Disoproxil Fumarate (Tenofovir DF) Versus Emtricitabine/Tenofovir DF in Subjects Resistant to Lamivudine

Who this might be right for
Hepatitis B
Gilead Sciences 280
Not applicableStudy completedNCT03348059
What this trial is testing

Anti-E1E2 (D32.10 Epitope-binding) Antibodies Status Prior Therapy Favors Direct-acting Antiviral Treatment Efficacy

Who this might be right for
Chronic Hepatitis c
Hospices Civils de Lyon 103
Not applicableStudy completedNCT00002310
What this trial is testing

SP-303T Applied to the Skin of Patients With Herpes Simplex Virus (HSV) Infection and AIDS Who Have Not Had Success With Acyclovir

Who this might be right for
Herpes SimplexHIV Infections
Shaman Pharmaceuticals
Early research (Phase 1)Active Not RecruitingNCT07300085
What this trial is testing

A Trial to Evaluate the Effect of CD388/MK1406 on the Immunogenicity of Fluzone® HD Vaccine (CD388.SQ.1.08/MK-1406-007)

Who this might be right for
Healthy Participants
Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 710
Testing effectiveness (Phase 2)Study completedNCT00334529
What this trial is testing

Alternative Oseltamivir Dosing Strategies

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 48
Testing effectiveness (Phase 2)Study completedNCT01012895
What this trial is testing

Study to Determine the Effectiveness of Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) Infected Patients Who Have Previously Failed Standard of Care

Who this might be right for
Chronic Hepatitis C
Bristol-Myers Squibb 215
Large-scale testing (Phase 3)Study completedNCT01773070
What this trial is testing

A Follow up Study Designed to Obtain Long Term Data on Participants Who Either Achieved a Sustained Virologic Response or Did Not Achieve a Sustained Virologic Response in an AbbVie Sponsored Hepatitis C Study

Who this might be right for
Hepatitis C
AbbVie (prior sponsor, Abbott) 478
Large-scale testing (Phase 3)Study completedNCT01258686
What this trial is testing

Clinical Study With Silymarin in the Patients With Chronic Hepatitis C Infection Who Failed Conventional Antiviral Therapy

Who this might be right for
Hepatitis C
Bukwang Pharmaceutical 53
Testing effectiveness (Phase 2)Ended earlyNCT04748783
What this trial is testing

Antiviral Efficacy and Acceptability of Mouth Rinses for Inactivation of COVID-19

Who this might be right for
COVID19Coronavirus InfectionSARS CoV-2 Infection
University of North Carolina, Chapel Hill 2
Large-scale testing (Phase 3)Study completedNCT00323804
What this trial is testing

Interest of Ribavirin in the Maintenance Treatment of Liver Fibrosis Using Low Dose Pegylated Interferon alpha2b in Patients With Chronic Hepatitis C Non Responders to Previous Antiviral Therapy.

Who this might be right for
Hepatitis C, ChronicLiver Fibrosis
ANRS, Emerging Infectious Diseases 372
Large-scale testing (Phase 3)UnknownNCT04017338
What this trial is testing

Transplantation Using Hepatitis C Positive Donors, A Safety Trial

Who this might be right for
Lung Transplant InfectionHeart Transplant InfectionKidney Transplant Infection+2 more
Jordan Feld 40
Early research (Phase 1)Study completedNCT04248426
What this trial is testing

Double-Blinded Study for Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of ATI-2173 in Healthy Subjects and Subjects With Chronic Hepatitis B Virus Infection

Who this might be right for
Hepatitis B, Chronic
Antios Therapeutics, Inc 88
Next Page